<DOC>
	<DOCNO>NCT00979979</DOCNO>
	<brief_summary>Hepatitis C virus ( HCV ) infection , lead cause cirrhosis , hepatocellular carcinoma ( HCC ) liver transplantation , affect approximately 170 million individual worldwide . Combination peginterferon plus ribavirin therapy become current standard care chronic hepatitis C ( CHC ) patient , overall sustain virologic response ( SVR ) rate 54-63 % favorable response rate patient genotype 2/3 infection genotype 1/4 infection . Therefore , accurate pre-treatment HCV genotype evaluation paramount importance facilitate individualize therapy era response guide therapy specific-targeted antiviral therapy HCV ( STAT-C ) . Currently , direct HCV genetic sequence 5 ' untranslated terminal region ( 5'UTR ) non-structural 5B ( NS5B ) region subsequent phylogenetic tree analysis consider gold standard determine HCV genotype subtype . However , time-consuming need special laboratory setting . Several commercial available reverse hybridization type-specific probe assay ( Inno-LiPA II ) simplify direct sequence 5'UTR region use replace two region sequence method ( Trugene HCV 5 ' NC genotyping kit ) . Nonetheless , data overall diagnostic accuracy vary . The Abbott RealTime HCV Genotype II vitro reverse transcription-polymerase chain reaction ( RT-PCR ) assay determine genotype ( ) HCV plasma serum HCV-infected individual . Based genetic similarity , HCV classify six major genotype ( 1-6 ) numerous subtypes . HCV genotype predictive response HCV-infected patient peginterferon plus ribavirin combination therapy . The Abbott RealTime HCV Genotype II assay us Abbott m2000sp instrument processing sample Abbott m2000rt instrument amplification detection . Furthermore , Abbott m2000sp provide automated sample transfer reaction assembly assay reagent Abbott 96-Well Optical Reaction Plate . The investigator aim evaluate overall diagnostic accuracy currently available commercial HCV genotype kit ( Abbott RealTime HCV Genotype II ) use 5'UTR NS5A gene amplification direct sequence gold standard .</brief_summary>
	<brief_title>Clinical Performance Abbott RealTime Hepatitis C Virus ( HCV ) Genotype II Test</brief_title>
	<detailed_description>Hepatitis C virus ( HCV ) infection , lead cause cirrhosis , hepatocellular carcinoma ( HCC ) liver transplantation , affect approximately 170 million individual worldwide . Therefore , prevention HCV transmission early intervention HCV infection urgently need reduce halt liver-related morbidity mortality . Combination peginterferon plus ribavirin therapy become current standard care chronic hepatitis C ( CHC ) patient , overall sustain virologic response ( SVR ) rate 54-63 % favorable response rate patient genotype 2/3 infection genotype 1/4 infection . Therefore , accurate pre-treatment HCV genotype evaluation paramount importance facilitate individualize therapy era response guide therapy specific-targeted antiviral therapy HCV ( STAT-C ) . Currently , direct HCV genetic sequence 5 ' untranslated terminal region ( 5'UTR ) non-structural 5B ( NS5B ) region subsequent phylogenetic tree analysis consider gold standard determine HCV genotype subtype . However , time-consuming need special laboratory setting . Several commercial available reverse hybridization type-specific probe assay ( Inno-LiPA II ) simplify direct sequence 5'UTR region use replace two region sequence method ( Trugene HCV 5 ' NC genotyping kit ) . Nonetheless , data overall diagnostic accuracy vary . The Abbott RealTime HCV Genotype II vitro reverse transcription-polymerase chain reaction ( RT-PCR ) assay determine genotype ( ) HCV plasma serum HCV-infected individual . Based genetic similarity , HCV classify six major genotype ( 1-6 ) numerous subtypes . HCV genotype predictive response HCV-infected patient peginterferon plus ribavirin combination therapy . The Abbott RealTime HCV Genotype II assay us Abbott m2000sp instrument processing sample Abbott m2000rt instrument amplification detection . Furthermore , Abbott m2000sp provide automated sample transfer reaction assembly assay reagent Abbott 96-Well Optical Reaction Plate . The investigator aim evaluate overall diagnostic accuracy currently available commercial HCV genotype kit ( Abbott RealTime HCV Genotype II ) use 5'UTR NS5A gene amplification direct sequence gold standard .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>HCV patient positive antiHCV HCV RNA ( Cobas Taqman , Roche Diagnostics , LOQ:25 IU/mL LOD:10 IU/mL ) Patients sign informed consent Patients without sign informed consent HCV patient without detectable HCV RNA ( Cobas Taqman , Roche Diagnostics )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Genotype</keyword>
	<keyword>Realtime PCR</keyword>
</DOC>